We are live on
!
Find out more
PC
PA Capital Portfolio holdings
AUM
$142M
1-Year Est. Return
46.45%
This Fund
S&P 500
This Quarter
Est. Return
+47.04%
1 Year Est. Return
+46.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$25.1M
(+22%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-9.75%
Top 10 Holdings %
Top 10 Hldgs %
21.86%
Holding
213
New
51
Increased
30
Reduced
71
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlueLinx
BXC
|
+$1.49M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$1.41M |
| 3 |
Iron Mountain
IRM
|
+$1.01M |
| 4 |
Dropbox
DBX
|
+$963K |
| 5 |
RTX Corp
RTX
|
+$941K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIG
Big Lots, Inc.
BIG
|
+$1.44M |
| 2 |
AGN
Allergan plc
AGN
|
+$1.41M |
| 3 |
Euronet Worldwide
EEFT
|
+$1.36M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$1.35M |
| 5 |
XYZ
Block Inc
XYZ
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.59% |
| 2 | Financials | 14.33% |
| 3 | Industrials | 11.38% |
| 4 | Communication Services | 11.26% |
| 5 | Healthcare | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Personalis
PSNL
$1.25B
| $160K | 0.12% |
12,321
-18,020
| -59% | -$200K |
|
152
BrightView Holdings
BV
$1.24B
| $157K | 0.11% |
+14,000
| New | +$169K |
|
153
Organogenesis Holdings
ORGO
$324M
| $134K | 0.1% |
34,771
-10,242
| -23% | -$36.9K |
|
|
GPMT
154
Granite Point Mortgage Trust
GPMT
$63.7M
| $129K | 0.09% |
+17,923
| New | +$97.3K |
|
|
EXFO
155
DELISTED
EXFO INC.
EXFO
| $125K | 0.09% |
44,500
| – | – |
|
156
Evolus
EOLS
$397M
| $98K | 0.07% |
18,432
-19,512
| -51% | -$89.9K |
|
157
Daktronics
DAKT
$946M
| $95K | 0.07% |
21,739
-70,164
| -76% | -$310K |
|
158
Gyre Therapeutics
GYRE
$629M
| $95K | 0.07% |
2,165
-1,092
| -34% | -$51.3K |
|
159
Dianthus Therapeutics
DNTH
$5.69B
| $83K | 0.06% |
+689
| New | +$97.1K |
|
|
EVFM
160
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $76K | 0.06% |
+1,785
| New | +$120K |
|
161
Xeris Biopharma Holdings
XERS
$1.45B
| $73K | 0.05% |
+27,420
| New | +$95.5K |
|
|
APEN
162
DELISTED
Apollo Endosurgery, Inc.
APEN
| $40K | 0.03% |
24,452
+2,404
| +11% | +$4.77K |
|
|
MITO
163
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $39K | 0.03% |
21,388
-1,073
| -5% | -$1.96K |
|
164
CALL
Chefs' Warehouse
CHEF
$4.31B
| $14K | 0.01% |
+1,000
| New | +$13.8K |
|
|
ZGNX
165
PUT
DELISTED
Zogenix, Inc.
ZGNX
| $14K | 0.01% |
+500
| New | +$13.8K |
|
|
166
CALL
Evolus
EOLS
$397M
| $13K | 0.01% |
2,400
-2,400
| -50% | -$11.1K |
|
167
AC Immune
ACIU
$231M
| – | – |
-73,344
| Closed | -$507K |
|
168
AerCap
AER
$23.4B
| – | – |
-9,647
| Closed | -$220K |
|
169
Airgain
AIRG
$71.1M
| – | – |
-23,000
| Closed | -$170K |
|
170
AMN Healthcare
AMN
$1.35B
| – | – |
-6,172
| Closed | -$357K |
|
171
Digital Turbine
APPS
$982M
| – | – |
-124,000
| Closed | -$534K |
|
|
BLD
172
DELISTED
TopBuild
BLD
| – | – |
-2,841
| Closed | -$204K |
|
173
Blackstone Mortgage Trust
BXMT
$2.77B
| – | – |
-45,018
| Closed | -$838K |
|
174
Pathward Financial
CASH
$1.88B
| – | – |
-24,593
| Closed | -$534K |
|
175
CoStar Group
CSGP
$12.2B
| – | – |
-3,940
| Closed | -$231K |
|
Similar funds
AW
CP
DCM
WOA
CFG
BCWM
RIM
SCM
PA Capital's Q2 2020 Portfolio in Review
As of Q2 2020, PA Capital held 213 positions worth $138M, up 22% from $113M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
PA Capital withdrew a net $13.5M in Q2 2020, closing 45 positions and reducing 71 holdings. Its most notable exit was Allergan plc, an estimated $1.41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.
Against the trend, PA Capital opened a new position in BlueLinx worth $2.07M.
- PA Capital's largest Q2 2020 buy was BlueLinx: 241,643 shares worth $2.07M.
- PA Capital added most to Fiserv Inc in Q2 2020, an estimated $1.41M increase.
- PA Capital's biggest Q2 2020 reduction was Big Lots, Inc., cutting an estimated $1.44M.
- PA Capital fully exited Allergan plc in Q2 2020, selling an estimated $1.41M.
- PA Capital's ten largest holdings make up 22% of its $138M portfolio in Q2 2020.
- PA Capital opened 51 new positions and closed 45 in Q2 2020.
- PA Capital's portfolio value rose 22% quarter-over-quarter to $138M.
Based on PA Capital's 13F filing for Q2 2020, filed 13 Aug 2020.